期刊文献+

苓桂术甘配方颗粒治疗慢性心力衰竭(心肾阳虚证)的临床观察 被引量:7

Clinical Effect of Linggui Zhugan Formula Granule on Chronic Heart Failure with Heart-Kidney Yang Deficiency Syndrome
下载PDF
导出
摘要 目的观察苓桂术甘配方颗粒治疗慢性心力衰竭(心肾阳虚证)的临床疗效及治疗结束后3月内的复发率情况。方法将60例符合慢性心力衰竭Ⅱ-Ⅲ级(心肾阳虚证)诊断标准的患者随机分为中药配方颗粒治疗组、中药饮片治疗组与对照组,每组20例,中药配方颗粒组予西药常规治疗加苓桂术甘颗粒,中药饮片组予西药常规治疗加苓桂术甘饮片,对照组单予西药常规治疗,疗程均为两周。观察治疗前后患者临床症状、总有效率、左室射血分数(LVEF)、血浆脑尿钠肽(brain natriuretic peptide,BNP)的变化及治疗结束后3个月内复发率情况。结果治疗2周后,中药配方颗粒组患者心功能改善总有效率为95%,中医证候改善总有效率为85%,复发率为10%,与对照组比较,差异具有统计学意义(P<0.025);治疗后中药配方颗粒组左室射血分数(LVEF)显著提高、血液中BNP浓度明显降低(P<0.01);中药配方颗粒组与饮片治疗组差异无统计学意义(P>0.05),中药配方颗粒组与饮片组疗效相当。结论苓桂术甘配方颗粒可有效缓解慢性心力衰竭Ⅱ-Ⅲ级(心肾阳虚证)患者的中医证候,改善左室收缩功能,提高左室射血分数,明显降低血浆BNP含量,中西医结合治疗较单纯西药治疗副作用少,3个月内复发率低,服用方便,临床安全性及依从性更好。 Objective To observe the clinical effect and the recurrence rate in 3 months of Linggui Zhugan formu-la granule on chronic heart failure with heart-kidney Yang deficiency syndrome. Methods 60 patients were randomly divided into Chinese medicinal ganule group treated with Linggui Zhugan formula granule combined with Western medicine conven-tional therapy, Chinese medicinal decoction pieces group treated with Linggui Zhugan decoction pieces combined with West-ern medicine conventional therapy, control group treated with routine Western Medicine, the treatment course was for 2 weeks, 20 cases in each group. The clinical symptoms, total effective rate, left ventricular ejection fraction (LVEF), plasma brain natriuetic peptide (BNP), and the recurrence rate in 3 months were observed before and after treatment. Results After treatment for 2 weeks, compared with the control group, the total effective rate in Chinese medicine formula granule group was 95%, the effective rate of Chinese medicine syndrome was 85%, and the recurrence rate was 10% in formula granule group, there were significant differences between the two groups (P〈0.05). The LVEF in Chinese medicine formula granule group sig-nificantly increased and BNP level decreased (P〈0.01), there was no statistically significant differences between the Chi-nese medicine granule group and decoction pieces group (P〉0.05). Conclusion Linggui Zhugan formula granule could effective-ly relieve chronic heart failure Ⅱ-Ⅲ with heart-kidney deficiency syndrome, improve left ventricular systolic function, increase left ventricular ejection fraction, reduce BNP content in plasma, and the recurrence rate in 3 months is low. Combination of TCM and Western medicine shows less side effects, good clinical safety and compliance.
作者 李克营 杨芳
出处 《湖南中医药大学学报》 CAS 2017年第8期895-899,共5页 Journal of Hunan University of Chinese Medicine
基金 湖南省研究生创新研究计划项目(CX2015B316)
关键词 慢性心力衰竭 苓桂术甘配方颗粒 心肾阳虚证 chronic heart failure Linggui Zhugan formula granule heart-kidney Yang deficiency syndrome
  • 相关文献

参考文献3

二级参考文献15

  • 1李小球,耿小茵,王沙燕,蒋红玉,赖真.苓桂术甘汤治疗充血性心力衰竭的临床研究[J].中华中医药杂志,2005,20(4):220-222. 被引量:29
  • 2Bittner V,Weiner DH,Yusuf S,et al.Prediction of mortality and morbidity with a 6 minute walk test in patients with left ventricular dysfunction SOLVD Investigtors[J].JAMA,1993,270(14):1702-1707.
  • 3Nishikimi T,Kuwahara K,Nakao K.Current biochemistry,mo-lecular biology,and clinical relevance of natriuretic peptides[J].JCardiol,2011,57(2):131.
  • 4Vanderheyden M,Vrints C,Verstreken S,et al.B-type natriureticpeptide as a marker of heart failure:new insights from biochemis-try and clinical implications[J].Biomark Med,2010,4(2):315.
  • 5Tosa S,Watanabe H,Iino K,et al.Usefulness of plasma BNP lev-els as a marker of left ventricular wall stress in obese individuals[J].Int Heart J,2009,50(2):173.
  • 6Farmakis D,Parissis JT,Bistola V,et al.Plasma B-type natriuret-ic peptide reduction predicts long-term response to levosimendantherapy in acutely decompensated chronic heart failure[J].Int JCardiol,2010,139(1):75.
  • 7Ritchie RH,Rosenkranz AC,Kaye DM.B-type natriuretic pep-tide:endogenous regulator of myocardial structure,biomarkerand therapeutic target[J].Curr Mol Med,2009,9(7):814.
  • 8Clerico A,Fontana M,Ripoli A,et al.Clinical relevance of BNPmeasurement in the follow-up of patients with chronic heart fail-ure[J].Adv Clin Chem,2009,48:163.
  • 9O'Donoghue M,Braunwald E.Natriuretic peptides in heart fail-ure:should therapy be guided by BNP levels?[J].Nat Rev Car-diol,2010,7(1):13.
  • 10Donadini MP,Squizzato A,Dentali F,et al.Prognostic stratifica-tion of chronic heart failure in elderly population:are cardiopul-monary tests and BNP really valuable?[J].Intern Emerg Med,2009,4(4):353.

共引文献67

同被引文献94

引证文献7

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部